The effects of hydroporation on melasma with anti-aging cocktail

J Cosmet Dermatol. 2017 Dec;16(4):e15-e20. doi: 10.1111/jocd.12313. Epub 2017 Jan 29.

Abstract

Background: Jet-M is a device for epidermal peeling and is used to deliver substances by spraying air and microdroplets. Previously, a case was treated with a mixed solution of copper-GHK, oligo-hyaluronic acid, Rhodiola extract, tranexamic acid, and β-glucan. The results showed significant improvement of aged skin.

Aims: This study was conducted to evaluate the effects of hydroporation on melasma with the formulation in a small group of volunteers.

Methods: Clinical effects were evaluated by both subjective and objective methods including melanin index (MI) and erythema index (EI) measurement.

Results: Clinically, pigmentation and erythema were relieved and also both MI and EI decreased. Histopathologic observation revealed that type IV collagen and procollagen were increased in the upper dermis. Furthermore, the number of p63-positive cells is increased along the basement membrane. These results all suggest that hydroporation with GHR formulation induced anti-aging effects by reconstruction of extracellular matrix.

Conclusion: These findings suggest that the treatment may have depigmenting effects and erythema decreasing effects by enhancing the microenvironment of the skin.

Keywords: Jet-M; basement membrane; collagen; hydroporation; melasma.

MeSH terms

  • Antifibrinolytic Agents / therapeutic use*
  • Collagen Type IV / metabolism
  • Copper / chemistry*
  • Dermatologic Agents / therapeutic use*
  • Dermis / metabolism
  • Dermis / pathology
  • Drug Combinations
  • Erythema / drug therapy
  • Extracellular Matrix / drug effects
  • Humans
  • Hyaluronic Acid / therapeutic use*
  • Keratinocytes / metabolism
  • Melanosis / drug therapy*
  • Melanosis / pathology
  • Membrane Proteins / metabolism
  • Oligopeptides / therapeutic use*
  • Plant Extracts / therapeutic use*
  • Procollagen / metabolism
  • Rhodiola*
  • Severity of Illness Index
  • Tranexamic Acid / therapeutic use*
  • beta-Glucans / therapeutic use*

Substances

  • Antifibrinolytic Agents
  • CKAP4 protein, human
  • Collagen Type IV
  • Dermatologic Agents
  • Drug Combinations
  • Membrane Proteins
  • Oligopeptides
  • Plant Extracts
  • Procollagen
  • beta-Glucans
  • Tranexamic Acid
  • Copper
  • Hyaluronic Acid